Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. 4 Shares withheld for taxes President and COO gave up 3,098 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Executive Officer gave up 5,212 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP,Finance & Strategy and CFO gave up 2,309 shares (to pay taxes)
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. 4 Open-market sale Director sold 5,083 shares at $213.14 ($1,083,410)
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. 4 Open-market sale Director sold 14,670 shares at an average $208.53 ($3,059,123)
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 4 Open-market sale Chief Executive Officer sold 54,666 shares at $203.40 ($11,119,239)
  14. SC 13G Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 4 Open-market sale SVP, Gen. Counsel & Secretary sold 18,097 shares at $178.50 ($3,230,376)
  17. 4 Open-market sale President and COO sold 44,547 shares at $176.86 ($7,878,582)
  18. 4 Grant or award Chief Executive Officer acquired 12,608 shares (grant or award)
  19. 4 Grant or award EVP,Finance & Strategy and CFO acquired 10,819 shares (grant or award)
  20. 8-K Event Results of operations

Page 26 of 115 · 2,300 filings